Startup | November 29, 2021
ZenOnco.io raises US $ 1.4 mn in seed funding
The funds will be used to scale up existing operations and launch new products
The funds will be used to scale up existing operations and launch new products
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
Lifebit's accompanying suite of AI-powered end-to-end software solutions provide faster data insights, accelerate drug discovery pipelines, and improve clinical trials success
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
The startup’s AI platform uses AI algorithms to automatically detect abnormalities and diseases in medical images, reducing patient misdiagnosis and increasing radiologists’ productivity
The company plans to invest in technology, business development, product innovation, and development across India
The financing secures funds to advance the clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April, through Phase IIa, targeting COPD as a primary indication
Founded in 2019, the start-up develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology
Subscribe To Our Newsletter & Stay Updated
